English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 73 | Tables: 68 | Pharma & Healthcare
The global market for 23-Valent Pneumococcal Polysaccharide Vaccine was valued at US$ 1211 million in the year 2024 and is projected to reach a revised size of US$ 2380 million by 2031, growing at a CAGR of 10.3% during the forecast period.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Market Drivers:
The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.
Market Challenges:
However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine.
The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Sinovac
Kangtai Bio
CDIBP
Walvax
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
For Children (Over 2 Years Old)
For Adult
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 23-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Definition
1.2 23-Valent Pneumococcal Polysaccharide Vaccine by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value by Application (2024 VS 2031)
1.3.2 For Children (Over 2 Years Old)
1.3.3 For Adult
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2020-2031
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2020-2031
1.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
2.7 Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
2.8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.8.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Scenario by Region
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2020-2031
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2020-2025
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2026-2031
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020-2031
3.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020-2025
3.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2026-2031
3.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.4.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.5.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.7.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2031)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2026-2031)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2031)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2031)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2025)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2026-2031)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2031)
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2026-2031)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2031)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2031)
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2025)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2026-2031)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sinovac
6.2.1 Sinovac Company Information
6.2.2 Sinovac Description and Business Overview
6.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Sinovac Recent Developments/Updates
6.3 Kangtai Bio
6.3.1 Kangtai Bio Company Information
6.3.2 Kangtai Bio Description and Business Overview
6.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Kangtai Bio Recent Developments/Updates
6.4 CDIBP
6.4.1 CDIBP Company Information
6.4.2 CDIBP Description and Business Overview
6.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.4.5 CDIBP Recent Developments/Updates
6.5 Walvax
6.5.1 Walvax Company Information
6.5.2 Walvax Description and Business Overview
6.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Walvax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process Analysis
7.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
7.5 23-Valent Pneumococcal Polysaccharide Vaccine Customer Analysis
8 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sinovac Company Information
Table 76. Sinovac Description and Business Overview
Table 77. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 79. Sinovac Recent Developments/Updates
Table 80. Kangtai Bio Company Information
Table 81. Kangtai Bio Description and Business Overview
Table 82. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 84. Kangtai Bio Recent Developments/Updates
Table 85. CDIBP Company Information
Table 86. CDIBP Description and Business Overview
Table 87. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 89. CDIBP Recent Developments/Updates
Table 90. Walvax Company Information
Table 91. Walvax Description and Business Overview
Table 92. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 94. Walvax Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 98. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 99. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 100. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 101. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 102. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type: 2024 & 2031
Figure 4. Single Dose Vial Product Picture
Figure 5. Pre-filled Syringe Product Picture
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application: 2024 & 2031
Figure 8. For Children (Over 2 Years Old)
Figure 9. For Adult
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine in 2024
Figure 18. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2020-2031)
Figure 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2020-2031)
Figure 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
